Type 2 diabetes is driven by insulin resistance and pancreatic cell dysfunction
Potential benefits of using GLP-1 receptor agonists after gastric sleeve surgery include: Enhanced weight loss : Observational studies suggest post-bariatric patients using GLP-1 receptor agonists may achieve additional weight reduction, typically around 510% of body weight, though individual responses vary considerably Improved glycaemic control : Particularly beneficial for patients with type 2 diabetes or prediabetes, as GLP-1 agonists enhance insulin secretion and reduce blood glucose levels Reduced appetite : These medications can help patients who struggle with persistent hunger despite surgical intervention Cardiovascular benefits : Semaglutide has demonstrated cardiovascular risk reduction in people with established cardiovascular disease, which may benefit eligible post-bariatric patients with this specific risk profile Maintenance of weight loss : May help prevent weight regain during the critical maintenance phase Potential risks and considerations include: Gastrointestinal side effects : Nausea, vomiting, diarrhoea, and constipation are common, particularly during dose escalation
Conclusion Early identification and timely treatment are critical to preserving dental health and avoiding more serious consequences
Obesity, like high blood pressure or diabetes, is a chronic condition that often requires long-term management rather than a short-term fix
Start Slowly: If you choose to supplement, consider starting with a lower dose and gradually increasing it to assess your tolerance
Rybelsus is contraindicated in people with a personal or family history of medullary thyroid carcinoma and in people with multiple endocrine neoplasia syndrome type 2
